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Keeping mitosis in check
Mutations in an essential yeast gene, encoding DNA polymerase E,
abolish the dependence of mitosis on the completion of DNA replication,
suggesting that the replication complex provides the checkpoint signal.
The events of the eukaryotic cell cycle - such as DNA
replication, chromosome condensation and cell division
- can each be arrested if earlier cell-cycle events have not
been completed, or if damaged DNA is present. Hartwell
and Weinert [1] proposed that arrest is achieved through
controls called "checkpoints", which can monitor cellu-
lar events and delay cell-cycle progression if necessary. By
definition, mutants deficient in these checkpoints pro-
gress through the cell cycle under conditions that would
normally induce arrest. Efficient checkpoint control
depends on a multi-step process, analogous to signal
transduction, that allows information to be 'transmitted'
between the functionally distinct protein complexes res-
ponsible for controlling different aspects of the cell cycle.
One approach to the study of checkpoints has been the
identification of checkpoint-deficient mutants in the
yeasts Saccharomyces cerevisiae and Schizosaccharomyces pombe
(reviewed in [2]). In this article, we focus on the yeast
checkpoint that maintains the dependence of mitosis on
the prior completion of DNA replication.
There are two classes of yeast mutants in which cells
enter mitosis without first completing DNA replication
(see Table 1). The first class includes mutations in certain
S. pombe rad and hus genes, and S. cerevisiae MEC, RAD
and SAD genes (Table 1) [3-7]. The checkpoint defect in
these mutants is revealed by treating cells with inhibitors
of DNA replication. Instead of undergoing cell-cycle
arrest, the mutant cells proceed into mitosis and attempt
to segregate a single set of chromosomes, with lethal con-
sequences. These mutants are otherwise viable, although
in some cases complete deletion of the relevant gene is
lethal [5]. As these class 1 checkpoint mutants are viable,
they are unlikely to be have defects in replication or
mitosis. Instead, the mutations must disrupt the pathway
that ensures the interdependence of these two processes
(see Fig. 1). Many of these mutations also abolish the
ability of cells to arrest in response to damaged DNA,
suggesting that replication and damage are monitored by
similar processes. Although many of the genes affected by
these mutations have been cloned and sequenced, so far
this has provided little information on the molecular
mechanisms underlying checkpoint control.
The second class of mutations disrupts functions that are
essential for the initiation of DNA replication in S phase
Fig. 1. Model for the molecular basis of
the phenotypes of different classes of
checkpoint mutant. In wild-type cells,
the presence of a replication complex
activates a checkpoint that inhibits
mitosis. Class 1 mutants have defects in
this checkpoint pathway. Class 2
mutants fail to assemble a replication
complex, so the checkpoint is not
activated. Polymerase E mutants, which
are viable but checkpoint-defective,
have lost the ability of the replication
complex to activate the checkpoint.
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(see Table 1). Included in the second class are mutations
in the S. pombe cdcl8, cut5/rad4 and cdtl genes [8-11].
These mutants are not viable, as they are unable to syn-
thesize DNA. However, instead of undergoing cell-cycle
arrest, like many other S-phase-defective yeast mutants,
the cells with class 1 mutations progress into mitosis.
Thus, in addition to disrupting DNA replication, these
mutations also abolish the checkpoint. Recently, del-
etions of the S. cerevisiae CDC6 gene have been shown to
have a similar phenotype (Piatti and Nasmyth, personal
communication).
To explain this phenotype, it has been proposed that
assembled replication complexes activate the checkpoint
pathway, thus inhibiting mitosis while replication is in
progress (Fig. 1). In mutants of class 2, replication com-
plexes are not assembled and so no inhibitory signal is
generated to arrest the cell cycle [8-12]. This model pre-
dicts that some component of the replication complex
interacts directly with the checkpoint 'signal transducing'
machinery. If this is the case, it should be possible to
isolate mutants in replication factors that are specifically
unable to transduce a checkpoint signal, but are able to
perform DNA replication normally. A mutation in the
S. cerevisiae gene encoding DNA polymerase e, recently
reported by Navas et al. [13], has these properties. The
identification of this mutant establishes that the replica-
tion complex is directly involved in checkpoint control
(see Fig. 1).
The polymerase E mutant was isolated in a screen for
S. cerevisiae mutants defective in the transcriptional res-
ponse to agents that damage DNA or block replication.
In response to such treatments, transcription of the
RNR3 gene (which encodes a subunit of ribonucleo-
tide reductase, RNR) is induced in wild-type cells.
Mutants which failed to induce RNR transcription
were identified; these dun (damage uninducible) mutants
fell into five complementation groups. Cells with
mutations in one gene, DUN2, also failed to arrest
mitosis when S-phase was blocked. The dun2 mutations
render cells temperature-sensitive for growth, although
the checkpoint and transcriptional defects are observed at
the permissive temperature.
Sequence analysis and classical genetics revealed that
DUN2 is identical to POL2, which encodes the catalytic
subunit of DNA polymerase E, one of three polymerases
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essential for DNA replication in S. cerevisiae [14-16].
Other studies suggest that polymerase can perform
leading-strand DNA synthesis and may also be involved
in DNA repair [17,18]. Navas et al. [13] examined other
available mutations in the POL2 gene and found that
only those mutations that affect the polymerase E car-
boxyl terminus abolished the checkpoint that monitors
unreplicated DNA. All these mutations are nonsense
mutations, resulting in truncations of polymerase E by
removing sequences immediately carboxy-terminal to a
zinc-finger domain that is conserved between the yeast
and human proteins [19]. In contrast, strains with muta-
tions affecting the polymerase's amino terminus display
defects in DNA replication at the restrictive temperature,
but arrest normally when DNA replication is blocked at
the permissive temperature. The carboxyl terminus con-
tains a zinc-finger motif which is unique to polymerase
e, and is thus unlikely to be involved in the polymeriza-
tion of nucleotides that all polymerases perform.
Furthermore, the checkpoint mutations do not abolish
DNA replication. It is therefore reasonable to propose
that the carboxyl terminus of polymerase E triggers a
biochemical pathway that culminates in mitotic arrest.
Moreover, it is also likely to trigger a distinct pathway
that culminates in transcriptional activation of damage-
inducible genes. Thus, this region of polymerase E seems
to play a central role in coordinating the response of cells
to failure to complete S phase.
Phenotypically, dun2 mutations in polymerase E resemble
mutations in the rad, MEC and hus genes classl genes;
see Table 1) which disrupt the checkpoint without
affecting S phase or mitosis. Perhaps these mutations
disrupt a checkpoint that is activated only when S phase
is arrested artificially. Alternatively, the checkpoint could
function during every cell cycle, blocking mitosis until
DNA replication is complete. Strains lacking polymerase
E are known to be nonviable and deficient in DNA
replication [14]. If the checkpoint is only required when
S phase is arrested artificially, complete deletion of the
polymerase E gene could result in normal cell-cycle
arrest. This would imply that the polymerase -depen-
dent checkpoint is required only for response to unusual
stimuli. However, if cells bearing the polymerase E
deletion enter mitosis (like cells with mutations in the
cdc18, cut5/rad4 and cdtl genes), it would seem that
polymerase E might also activate the mitotic checkpoint
during normal cell cycles.
What role is the carboxyl terminus of polymerase play-
ing in the checkpoint pathway? Navas et al. [13] propose
that it works as a sensor, detecting regions of single-
stranded DNA that form when DNA polymerase pro-
gression is blocked. The dun2 mutation, which affects a
site close to the zinc-finger DNA-binding motif, may
abolish the ability of this motif to bind and 'sense' single-
stranded DNA. Alternatively, the carboxyl terminus of
the polymerase could participate in protein-protein
interactions that activate the checkpoint pathway. These
interactions might only take place when polymerase is
assembled in a replication complex. According to this
model, the carboxyl terminus functions more as a signal
than as a sensor. To distinguish between these models,
genetic, biochemical and molecular techniques could be
used to identify factors that interact with the carboxyl
terminus of polymerase ; the role of any such proteins
in the checkpoint could then be assessed. It will also
be important to determine whether any of the MEC,
rad or hus gene products interact with the polymerase E
carboxyl terminus.
Disruption of checkpoint controls in the cells of higher
eukaryotes has been proposed to promote tumorigenesis
by increasing genetic instability [20]. Mutations in the
tumor suppressor gene p53 have been shown to disrupt
the checkpoint that ensures cell-cycle arrest at the G1- to
S-phase boundary in response to DNA damage, and also
to promote gene amplification and tumorigenesis (re-
viewed in [21]). The carboxyl terminus of polymerase E
has been conserved between S. cerevisiae and humans [19],
suggesting that its role in checkpoint control is also con-
served. Could carboxy-terminal truncations of the hu-
man DNA polymerase E increase genetic instability and
thus promote tumorigenesis? Perhaps studies in yeast are
pointing yet again to a novel class of tumor suppressors.
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